Abstract Library

Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.

Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.

 

Please note:

Participants of the 2025 ENETS Conference enjoy full access to the 2025 conference digital resources through myENETS: the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more.

Log in to myENETS

ENETS Abstract Search

#3243 The major impact of proGRP monitoring in advanced atypical lung carcinoid: A case report

Introduction: Atypical lung carcinoids (aLC) are more aggressive than typical carcinoids, metastasizing more commonly to distant sites, and require vigilant follow-up. However, the surveillance is often hampered by the non-informative Chromogranin A (CgA) levels.

Conference: 18th Annual ENETS Concerence (2021)

Presenting Author:

Authors: Oleinikov K, Ben-Haim S, Atlan K, Nisman B, Bloom A,

Keywords: pro-GRP, lung carcinoids, biomarker,

#1804 Open-Label Multicentre Single-Arm Phase 2 Trial of Lanreotide Autogel (LAN) in Combination with Temozolomide (TMZ) in Patients with Advanced Well/Moderately Differentiated Neuroendocrine Tumours (NETs) of Lung and Thymus: ATLANT

Introduction: In phase 3 CLARINET study, LAN 120mg every 28 days significantly prolonged progression-free survival (PFS) vs placebo in pts with well-differentiated metastatic enteropancreatic NETs, but limited data exist for somatostatin analogues in advanced lung/thymic NETs. Evidence that TMZ may be active in thoracic NETs is mainly retrospective.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author:

Authors: Ferolla P, Berruti A, Fazio N, Mazzanti P, Houchard A,

Keywords: Temozolomide, lanreotide,

#1041 Surgical Management of Carcinoid Valve Disease-Mechanical versus Tissue Valves

Introduction: The prosthetic valve of choice in patients with carcinoid valve disease (CVD) remains controversial due to the limited life expectancy of patients with advanced-stage neuroendocrine tumors (NETs) on one hand, and concerns regarding structural valve deterioration (SVD) on the other.

Conference: 12th Annual ENETSConcerence (2015)

Presenting Author: Glasberg S

Authors: Glasberg S, Atlan J, Korach A, Dabah A, Atlan K,

Keywords: carcinoid valve disease,